Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,066,480
+$26,026,189 QoQ
Shares Held
96,666
+2379.3% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#95
of 1,040 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $872,920,182 across 27 Diagnostics & Research names. LH ranks #11 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
581,332 | $218,022,752 | |
| 2 | QGEN |
Qiagen N.V.
|
3,491,480 | $136,516,866 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
76,977 | $98,338,886 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
342,995 | $77,787,835 | |
| 5 | DGX |
Quest Diagnostics Inc
|
269,760 | $57,175,631 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
93,128 | $49,026,303 | |
| 7 | TWST |
Twist Bioscience Corp
|
396,912 | $40,834,306 | |
| 8 | NTRA |
Natera, Inc.
|
131,663 | $35,739,920 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,066,480 | 96,666 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,040,291 | 3,899 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $45,046,756 | 179,555 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $178,996,262 | 623,550 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $91,378,680 | 348,096 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $16,115,150 | 69,241 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $6,236,208 | 27,905 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $305,265 | 1,500 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||